Integrated Proteins Intrinsic Value
INTEGFD Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹45.60 | ₹36.48 - ₹54.72 | +40.1% | EPS: ₹3.80, Sector P/E: 12x |
| Book Value Method | asset | ₹50.00 | ₹45.00 - ₹55.00 | +53.7% | Book Value/Share: ₹50.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹52.00 | ₹46.80 - ₹57.20 | +59.8% | Revenue/Share: ₹65.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹15.00 | ₹13.50 - ₹16.50 | -53.9% | EBITDA: ₹1.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹60.80 | ₹54.72 - ₹66.88 | +86.8% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹32.68 | ₹29.41 - ₹35.95 | +0.4% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| Graham Defensive Method | conservative | ₹65.38 | ₹58.84 - ₹71.92 | +100.9% | EPS: ₹3.80, BVPS: ₹50.00 |
Want to compare with current market value? Check INTEGFD share price latest .
Valuation Comparison Chart
INTEGFD Intrinsic Value Analysis
What is the intrinsic value of INTEGFD?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Integrated Proteins (INTEGFD) is ₹50.00 (median value). With the current market price of ₹32.54, this represents a +53.7% variance from our estimated fair value.
The valuation range spans from ₹15.00 to ₹65.38, indicating ₹15.00 - ₹65.38.
Is INTEGFD undervalued or overvalued?
Based on our multi-method analysis, Integrated Proteins (INTEGFD) appears to be trading below calculated value by approximately 53.7%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 1.60 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Operating Margin | -99.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.81x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Integrated Proteins
Additional stock information and data for INTEGFD
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-24 Cr | ₹-24 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |